Target intelligence / Profile preview

Ribosomal protein L13a pseudogene 25 (RPL13AP25)

Target
RPL13AP25
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein L13a pseudogene 25 (RPL13AP25) is a processed pseudogene of the functional ribosomal protein L13a gene (RPL13A). Pseudogenes such as RPL13AP25 lack the ability to encode functional proteins and are typically considered non-functional gene copies. They may be used as genomic markers but have no direct biological function, are not expressed as proteins, and have no established role as therapeutic targets or disease biomarkers[4][9]. The term "pseudogene" in its name indicates that this is not a gene that produces a functional ribosomal protein, but rather a non-functional or "dead" copy of such a gene[4][9]. The functional protein-coding gene is *RPL13A* (ribosomal protein L13a), which encodes a ribosomal protein component of the large (60S) ribosomal subunit and participates in translational regulation and inflammation, but RPL13AP25 does *not* produce this protein[1][3][5][7]. There is no evidence supporting biological, therapeutic, or diagnostic relevance for RPL13AP25 itself[4][9]. Consequently, RPL13AP25 is a pseudogene and is not considered a canonical target for drug development, disease association, or functional studies. Its main relevance is in genomic studies as a processed genomic remnant of the functional RPL13A gene[4][9].

Other names
FWP004RPL13A_11_1314S863-4RPL13AP25

Beyond the preview

Go deeper on Ribosomal protein L13a pseudogene 25 (RPL13AP25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L13a pseudogene 25 (RPL13AP25).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call